• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Skin Microbiota
        • In vitro microbiota assessment
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

IPS

News

SLAS 2018 : new drug opportunities from 3D, microfluidic and co-culture models

The 2nd Edition of SLAS advanced 3D human models and High-Content Analysis Conference was a great event with interesting presentations and posters from public labs and various companies. In regards of the different presentations, it seems obvious that developing 3D cell culture models is essential to find new leads relevant Read more…

By Grégory MAUBON, 2 years3 months ago
News

See you soon in Berlin for ESTIV2018

The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU CHOPIN, on the use of hepatocyte-like cells differentiated from human induced pluripotent stem cells (hiPSC) Read more…

By Nathalie MAUBON, 2 years3 months ago
Posters

Poster (with Ncardia) – Neurotoxicity assessment: Comparison between SH-SY5Y and human iPSC-derived brain cells

Ask for high quality link by entering your email below As shown by AstraZeneca in Nature reviews*, one third of the safety failures is linked to CNS toxicity during the clinical trials of drugs. Therefore, relevant in vitro human models are needed to detect early neurotoxicity of drug candidates. In Read more…

By Grégory MAUBON, 3 years3 months ago
News

See you next week on BioFIT 2017 event in Strasbourg!

Come and discover our programs on iPS and 3D culture

By Nathalie MAUBON, 3 years3 months ago
HCS, HCA & Biology

Feedback of Advances in Cell screening congress organized by ELRIG

3D culture, patients derived culture as iPS, phenotypic screening, machine learning to go to personalized medicine …

By Pierre Jean Ferron, 4 years4 years ago
News

PhD started for Meryl

Your children came back to school ? It is the same for Meryl Roudaut who also just begin his PhD training

By Nathalie MAUBON, 4 years3 months ago
HCS, HCA & Biology

Human in vitro micro-organs

Using iPS, researchers are moving very quickly in understanding cell differentiation and already manage to recreate a mini-organ in vitro after 20-30 days of differentiation

By Nathalie MAUBON, 5 years4 years ago
HCS, HCA & Biology

Phenotypic screening on patient derived-cells

To incresase the relevance of the early stage of drug research process, using patient derived-cells is really the good way. This can be now feasible by using iPSCs.

By Nathalie MAUBON, 5 years4 years ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • Agrément CIR jusqu’en 2023 pour HCS Pharma
  • Oxidative stress : definition and biological effects
  • On the importance of extracellular matrix of the skin for efficient 3D cell culture models
  • Welcome to Dr Philippe Manivet and Dr Anthony Trezeibre in our Scientific Advisory Board
  • [job position] Biomaterials Research Engineer (F/M)
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2020 | Hestia | Powered by WordPress